The effects of percutaneous coronary intervention on mortality in elderly patients with non-ST-segment elevation

Pınar D Gündoğmuş1, Emrah B Ölçü2, Ahmet Öz2

  • 1Medical Doctor, Department of Cardiology, 29 Mayıs State Hospital, Ankara/Turkey.

Scottish Medical Journal
|August 11, 2020
PubMed

Insights

Percutaneous coronary intervention effectively reduces one-year mortality in elderly patients with non-ST-segment elevation myocardial infarction (NSTEMI). This finding supports PCI as a valuable treatment strategy for this demographic, despite current underutilization.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Interventional Cardiology

Background:

  • Elderly patients with non-ST-segment elevation myocardial infarction (NSTEMI) are recommended for invasive revascularization assessment.
  • Current guidelines suggest PCI for NSTEMI, yet elderly patients receive fewer interventions.
  • This disparity highlights a need to evaluate PCI's effectiveness in older NSTEMI populations.

Purpose of the Study:

  • To assess the effectiveness of percutaneous coronary intervention (PCI) on all-cause mortality in elderly patients with NSTEMI.
  • To compare outcomes between conservative management and PCI in this patient group.
  • To identify predictors of mortality in older NSTEMI patients undergoing different treatment strategies.

Main Methods:

  • A cohort of 324 NSTEMI patients aged 65 or older was analyzed.
  • Patients were treated with either a conservative strategy or percutaneous coronary intervention (PCI).
  • Demographic, clinical characteristics, and one-month and one-year follow-up data were collected and analyzed.

Main Results:

  • 64.19% of patients underwent PCI, while 35.81% received conservative treatment.
  • PCI was found to be an independent predictor of reduced one-year mortality (HR: 1.965).
  • Killip class ≥2, reduced Left Ventricular Ejection Fraction, and renal failure independently predicted one-year mortality.

Conclusions:

  • Percutaneous coronary intervention (PCI) demonstrates effectiveness in reducing one-year mortality for NSTEMI patients over 65.
  • PCI is a viable strategy to decrease mortality in this elderly population.
  • Larger population studies are recommended to further validate these findings and inform clinical practice.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
136
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
513
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
161
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
163
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
160
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
725